A study to compare acceptability, safety and continuation rates of combined hormonal pill and centchroman as post abortion contraceptives

Inlo Miuli, Rupali Dewan, Kavita Agarwal


Background: Centchroman a non-steroidal selective estrogen receptor modifier (SERM). It is highly effective contraceptive which is devoid of side effects of COCs and there is prompt return of fertility upon discontinuation. Data in terms of its acceptability and continuation rates is limited when compared to combined oral contraceptive (COC). Therefore, the study was planned to study the acceptability, efficacy and continuation rates of centchroman and compare it with the combined oral contraceptives.

Methods: The study was a prospective interventional comparative randomized study carried out in the department of obstetrics and gynecology VMMC and SJH, New Delhi, for a period of 18 months from November 2018 to April 2019.

Results: A total of 945 women were screened and finally 240 women who met the criteria were recruited in 2 study groups of 120 women each. Majority were in the age group 18-28 years in either groups. Patients were followed up at 2nd week and then at 1st, 3rd, 6th and 12th months after initiation of the OCP with no loss to follow up. The pearl index in this study was 0.83 for ormeloxifene. The study showed statistically significant differences with higher level of satisfaction reported with 77.5% in the ormeloxifene compared to 65% of COCs. The continuation rates for ormeloxifene and COC users were in decreasing trend with increase in duration. No untoward events were reported with either formulation.

Conclusions: Both the hormonal, combined hormonal contraceptive [combined oral contraceptive (COC), MALA-N] and the non-hormonal, centchroman (ormeloxifene) oral contraceptive pills are safe, effective, well tolerated and not associated with adverse outcomes when used immediately after abortion. Continuation rates of the pills in both the groups decrease in trend with time.


Centchroman, Hormonal oral contraceptive pill, Pearl index, Postabortal contraception

Full Text:



WHO library cataloguing-in-publication data, unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008, 6th ed.; 2011. Available at: Accessed on 22nd February 2020.

Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contracept. 2003;67:87-91.

Postpartum IUD Reference Manual. New Delhi, India: Planning Division, Ministry of Health and Family Welfare Government of India; 2018. Available at: 2018/NHM_Components/RMNCHA/Family_planning/Schemes_&_Guidelines/IUCD/IUCD_Manual_English.pdf. Accessed on 22nd February 2020.

Nair HS, Jayasimhan P. A prospective study of centchroman users with special reference to its contraceptive benefit. J Evid Based Med Healthc. 2016;3(98):5374-80.

Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med. 2012;366(24):2257.

Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Lancet. 1996;348(9026):505.

Siritho S, Thrift AG, McNeil JJ, You RX, Davis SM, Donnan GA. Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke. 2003;34(7):1575-80.

Iversen L, Sivasubramaniam S, Lee AJ, Fielding S, Hannaford PC. Lifetime cancer risk and combined oral contraceptives: the Royal College of general practitioners’ oral contraception study. Am J Obstet Gynecol. 2017;216(6):580-e1.

Ganguli G. Mukherjee K. Raman N. Centchroman, a safe contraceptive coverage following medical termination of pregnancy. J Obstet Gynecol. 1995;649-65.

Berenson A B, Rahman M. A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms. Contracept. 2012;86(6):716-24.

Hou SP, Zhu WL, Li SM, Teng YC. Acceptance and continuation of contraceptive methods immediate postabortion. Gynecol Obstet Investigat. 2017;82(1):86-95.

Yadav VK, Sharma P, Sharma R, Yadav J. Centchroman a better alternative for hormonal oral contraceptive pills. Int J Pharm Bio Sci. 2011;2(1):587-92.

Tripney J, Kwan I, Bird KS. Postabortion family planning counseling and services for women in low-income countries: a systematic review. Contracept. 2013;87:17-25.

Rose SB, Cooper AJ, Baker NK, Lawton B: Attitudes toward long-acting reversible contraception among young women seeking abortion. J Womens Health (Larchmt). 2011;20:1729-35.